Clinical trial

Persistence, Adherence, Quality of Life, and Treatment Satisfaction With Avonex® PEN™.

NCT01405872

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

OTHER · Unmapped registry intervention AVONEX PEN Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Persistence, Adherence, Quality of Life, and Treatment Satisfaction With Avonex® PEN™.

Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2011-09-01

PhaseN/A

Conditions

Multiple Sclerosisverified · MONDO: multiple sclerosis

Interventions

AVONEX PENOTHER

Sponsors & collaborators

Biogenlead sponsor

Mapped research locations

BerlinGermany1 HamburgGermany1 StrasbourgFrance1 StockholmSweden1 MünchenGermany1 DresdenGermany1 Clermont-FerrandFrance1 GlasgowUnited Kingdom1 RouenFrance1 CréteilFrance1 SheffieldUnited Kingdom1 Freiburg im BreisgauGermany1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01405872 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.